Hypertrophic cardiomyopathy (HCM), which was first described in 1958, occurs in approximately one in 500 people. Patients with HCM are at an increased risk of atrial fibrillation, which is not ...
Context: On the basis of theoretical rationale, heparoids and vitamin K antagonists are prescribed ... molecular-weight heparins or thrombolytic drugs have been done; therefore, their efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback